UM Lublin · biotech-diagnostics · ABM 5.1M PLN · cardio
H215 · AXL signaling
71
IIMCB · discovery-science · NCN OPUS · NSCLC
Projects
Project database · 859 indexed
7 active filters
Systematic selection: every project characterized in 16 dimensions, scored on a 0–100 scale and assigned to a funnel stage.
Filter by domain, therapeutic area, source, institution, scoring threshold and pipeline status.
Domain
675
157
27
Therapeutic area
153
124
111
54
51
50
Sub-domain
198
87
62
54
8
Source
299
60
46
95
Quality score
0≥ 60100
Pipeline stage
6
5
17
↻ clear filters
Biotech
Oncology
NCN + ABM
quality ≥60
→ 47 matches
sort by score (desc) ▾
87
SCORE
DOG-AMP — Deep Optimised Generation of Antimicrobial Peptides
CAR-T adoptive immunotherapy for pancreatic ductal carcinoma
dr Marcin Piejko · UJ Collegium Medicum
drug-discovery · cell therapy · pancreatic ductal · development phase
biotechCAR-Toncology
11.7M PLN
ABM KPO
›
64
SCORE
Radiogenomics for primary brain tumor genotyping (MRI + 1H-MRS)
H14 · prof. Barbara Bobek-Billewicz · Maria Skłodowska-Curie NIO Gliwice
biotech-diagnostics · AI imaging · IDH mutation · 2HG biomarker
biotechimaging+AIoncology
3.04M PLN
ABM KPO
›
62
SCORE
AK4 enzyme inhibitor — metabolic reprogramming in NSCLC
H188 · dr Magdalena Wujak · Nicolaus Copernicus University Toruń
drug-discovery · small molecule · NSCLC · preclinical
biotechdrug discoveryoncology
2.1M PLN
NCN SONATA
›
↓ 40 more · show all
Currently shown
47
projects after filtering
biotech · oncology · NCN/ABM · q≥60
€42M
cumulative budget
grants combined across 47 projects
Score distribution
80–100
1
60–79
46
40–59
74
0–39
26
Top institutions (in filter)
UJ CM
12
IMDiK PAN
8
WUM
6
UMK
5
UMLub
4
Activity (last 30 days)
+47 new projects
+12 enriched to L2
+5 added to shortlist
2 moved to due diligence
Pipeline
Selection funnel · current state
Every project flows through a 5-stage process: from source identification, through cataloging and triage, to in-depth evaluation and due diligence.
Conversion funnel
End-to-end systematic process. Conversion rates are calibrated quarterly against deal-flow targets.
1.2%
end-to-end conversion
4–6 wk
average evaluation time
SOURCING
8 channels · automated + manual
859
100%
LISTING
indexed + L2 enrichment
646
75%
TRIAGE
16-dimensional scoring
292
34%
SELECTION
active pipeline + shortlist
114
13%
DUE DILIGENCE
deep evaluation + VB process
10
1.2%
Active stages
Projects under review · extract
Inbox
70
CB_006 · DOG-AMP
UW · ERC CoG · AI / AMP
H21 · MicroAIvag
UJ CM · ABM 2M PLN
H235 · PersonALL
SUM · pediatric oncology
Long list
17
H215 · AXL signaling
IIMCB · NCN OPUS
H26 · Organoid platform
IMDiK · ABM 8.1M PLN
H3 · AAA biomarker test
UM Lublin · ABM 5.1M PLN
Active lead
16
H188 · AK4 / NSCLC
drug discovery · oncology
Stapled peptides
PŁ · diabetes
Due diligence
10
H14 · Radiogenomics MRI
NIO Gliwice · 2HG IDH
CAR-T pancreatic
UJ CM · ABM 11.7M PLN
Closed deal
2
[VB Process]
confidential
Sourcing
Discovery channels · live sync status
8 active discovery channels feeding the database. Each pipeline runs on its own cadence with quality + dedup checks.
NCN
National Science Centre · Polish R&D grants
299
projects ingested
● synced 2h ago
Daily cadence
97% match rate
CTT / Patents
Technology Transfer Offices · patent registry
95
projects ingested
● synced today
Weekly cadence
89% match rate
ABM
Medical Research Agency · KPO program
60
projects ingested
● synced 9h ago
Daily cadence
100% match rate
CORDIS
EU research projects database
46
projects ingested
● synced 4h ago
Daily cadence
92% match rate
PubMed
Biomedical literature surveillance
38
projects ingested
● synced today
Daily cadence
78% match rate
EU Horizon
Horizon Europe consortia tracking
30
projects ingested
● synced 4d ago
Weekly cadence
94% match rate
FNP
Foundation for Polish Science · TEAM-NET / FIRST-TEAM
28
projects ingested
● synced 1d ago
Weekly cadence
96% match rate
NCBR
National Centre for Research and Development · STRATEGMED, INFOSTRATEG
14
projects ingested
● synced 5d ago
Weekly cadence
91% match rate
Recent ingests · last 30 days
NCN+12 OPUS 27 grants (oncology cluster)
9h ago
CORDIS+5 Horizon Europe Health cluster grants
2d ago
ABM2024/ABM/04/KPO results — 8 new projects flagged
4d ago
PubMed+22 papers w/ PI-institution match (auto-attached)
5d ago
CTTWUT TTO · 3 patent applications in immuno-oncology
1w ago
Coverage quality
Quality of each channel measured by match rate (% of incoming records successfully de-duplicated against the master DB) and freshness (median lag from source publication to ingest).
ABM
100%
NCN
97%
FNP
96%
EU Horizon
94%
CORDIS
92%
NCBR
91%
CTT / Patents
89%
PubMed
78%
Reports
Generate reports from the database
Built-in templates and custom report generation. Outputs available as PDF, PPTX or shareable HTML.
Build from scratch — pick projects, fields, charts. Save as new template.
Builderstart blank
Recently generated
Last 5 reports
🎯
Oncology Landscape — PL biotech
TA Landscape · 14 slides · 47 projects
biotech
3 days ago
PDF ↓
💼
Q2 Investor Brief · The Heart Ventures
Investor Brief · 9 slides · top 12 selections
internal
1 week ago
PPTX ↓
🔬
CB_006 · DOG-AMP — full dossier
Project Dossier · 6 pages · Szczurek lab
techbio
1 week ago
PDF ↓
📊
Q1 2026 — Quarterly Update
Quarterly · 11 slides · +147 projects ingested
internal
2 weeks ago
PPTX ↓
🎯
AMR Landscape · client brief
TA Landscape · 11 slides · Merck KGaA brief
biotech
3 weeks ago
PDF ↓
Knowledge Graph
Scouting · 859 projects · live ontology
Each node is a real entity from the database — projects, researchers, institutions, grants, publications. Relationships are real triples in the knowledge graph.
DOG-AMP — Deep Optimised Generation of Antimicrobial Peptides
prof. Ewa Szczurek · University of Warsaw (MIM) + Helmholtz Munich (AI for Health, co-director) · ORCID 0000-0002-1320-6695
Overview
Network
Target & Market
Sources (4)
Notes
Metadata
Scoring
Composite score · 4 evaluation axes
87
/ 100
COMPOSITE
Stage
3/5
Novelty
5/5
Commercial fit
4/5
Team access
5/5
Analytical depth
16-dimensional scoring matrix
Science
Mechanism clarity
Science
Foundational evidence
Science
Reproducibility
Science
Patent landscape
Market
Market size
Market
Reimbursement
Market
Time to revenue
Market
Competitive moat
Team
PI track record
Team
International ties
Team
Commercial mindset
Team
Operational maturity
Risk
Technical risk
Risk
Regulatory risk
Risk
IP risk
Risk
Talent capture
Evidence chain
Verbatim quotes from verified sources
Sub-domain · techbio
"Deep optimised generation models represent a new class of artificial intelligence methods. The models will be used to simultaneously generate and optimise generated samples."
VERIFIEDUW Press Release · Dec 2023
Approach · ai-driven-discovery
"Antimicrobial resistance: variational autoencoders to the rescue! We work out specialized deep generative models to produce synthetic antimicrobial peptides."
VERIFIEDHelmholtz Munich · AI for Health lab page · 2024
Funding · ERC CoG €2M
"Prof. Szczurek received the Consolidator Grant awarded by the European Research Council (ERC) — almost €2 million — project starts May 2024, runs until May 2029."
VERIFIEDUW EN news · Dec 1, 2023
BD Conclusion
Sales-first framing
Operator note · @zles
Excellent candidate for a techbio entry point into the AMR portfolio. Szczurek = top-tier international AI competence with local PL ties (GUMed/UW). Action: schedule a 15-min discovery call in Q3 2026 — assess appetite for commercialization + spin-out potential. Possible fit as a seed in VB process or direct license deal with big pharma (AMR pipelines are dry).
Last updated: May 30, 2026 · ZL · 16-dim scoring + evidence chain + grant verification